Deepak L Bhatt Selected Research

Pathologic Constriction (Stenosis)

4/2024	Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography.
1/2023	External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry.
10/2022	Predicting radiocephalic arteriovenous fistula success with machine learning.
10/2021	A novel technique for invasive aortic valve pressure gradient measurement using a 6 Fr Swan-Ganz catheter: a case series.
1/2021	Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.
10/2020	Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.
9/2019	Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
5/2019	Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study.
11/2018	Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Intervention.
10/2018	Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deepak L Bhatt Research Topics

Disease

340	Myocardial Infarction 05/2024 - 01/2002
276	Hemorrhage 04/2024 - 06/2002
205	Stroke (Strokes) 04/2024 - 04/2002
165	Acute Coronary Syndrome 01/2024 - 04/2002
159	Thrombosis (Thrombus) 03/2024 - 02/2002
157	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 01/2002
145	Heart Failure 04/2024 - 07/2007
117	Type 2 Diabetes Mellitus (MODY) 04/2024 - 05/2010
110	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 04/2002
98	Ischemic Stroke 04/2024 - 02/2004
92	Atrial Fibrillation 01/2024 - 01/2008
67	ST Elevation Myocardial Infarction 12/2022 - 05/2003
60	Diabetes Mellitus 04/2024 - 09/2002
56	Hypertension (High Blood Pressure) 12/2023 - 01/2006
54	Peripheral Arterial Disease 05/2024 - 08/2004
47	Ischemia 04/2024 - 02/2004
42	Unstable Angina 04/2024 - 04/2003
36	Chronic Renal Insufficiency 04/2024 - 05/2002
34	Atherosclerosis 04/2024 - 07/2003
33	Vascular Diseases (Vascular Disease) 12/2023 - 09/2005
29	Coronary Disease (Coronary Heart Disease) 05/2024 - 03/2003
29	Inflammation (Inflammations) 02/2024 - 02/2002
25	Obesity 12/2023 - 07/2006
19	Neoplasms (Cancer) 10/2023 - 12/2009
17	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023 - 01/2012
16	Dyslipidemias (Dyslipidemia) 02/2024 - 07/2006
16	COVID-19 01/2024 - 09/2020
15	Pathologic Constriction (Stenosis) 04/2024 - 03/2004
14	Infections 08/2023 - 10/2018
14	Weight Loss (Weight Reduction) 01/2023 - 07/2006
13	Hypertriglyceridemia 03/2024 - 07/2006
13	Kidney Diseases (Kidney Disease) 12/2023 - 01/2018
13	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2017
13	Cardiogenic Shock 01/2022 - 01/2002
12	Non-ST Elevated Myocardial Infarction 02/2022 - 07/2009
11	Rheumatoid Arthritis 04/2024 - 01/2019
11	Cerebral Hemorrhage 02/2024 - 11/2011
11	Body Weight (Weight, Body) 01/2024 - 04/2008
10	Renal Insufficiency (Renal Failure) 02/2024 - 04/2005

Drug/Important Bio-Agent (IBA)

178	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2024 - 06/2002
133	Clopidogrel (Plavix)FDA Link 01/2024 - 01/2002
94	omega-Chloroacetophenone (Mace)IBA 04/2024 - 01/2002
89	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 02/2002
59	TicagrelorIBA 04/2024 - 03/2013
55	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2024 - 06/2010
50	AnticoagulantsIBA 01/2023 - 01/2005
44	cangrelorIBA 03/2022 - 12/2009
39	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2006
38	RivaroxabanIBA 05/2024 - 01/2012
36	LipidsIBA 01/2024 - 02/2002
34	LDL CholesterolIBA 03/2024 - 09/2009
34	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 05/2007
33	eicosapentaenoic acid ethyl esterIBA 04/2024 - 01/2019
32	dapagliflozinIBA 10/2023 - 01/2018
31	alirocumabIBA 04/2024 - 11/2014
31	Warfarin (Coumadin)FDA LinkGeneric 12/2021 - 10/2011
27	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2023 - 05/2002
26	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2004
25	CholesterolIBA 04/2024 - 12/2006
25	Triglycerides (Triacylglycerol)IBA 03/2024 - 08/2010
25	Sodium-Glucose Transport ProteinsIBA 10/2023 - 11/2018
24	oxidized low density lipoproteinIBA 01/2024 - 09/2009
24	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 01/2018
23	Dabigatran FDA Link 01/2022 - 07/2015
22	saxagliptin FDA Link 11/2021 - 11/2011
19	CreatinineIBA 10/2023 - 10/2003
18	Prasugrel Hydrochloride FDA Link 01/2024 - 05/2008
18	MetalsIBA 01/2021 - 03/2005
17	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 06/2009
17	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 10/2008
16	SodiumIBA 04/2024 - 01/2018
16	C-Reactive ProteinIBA 02/2024 - 07/2003
15	empagliflozinIBA 04/2024 - 11/2018
15	TroponinIBA 07/2023 - 08/2015
15	Vitamin K FDA Link 01/2023 - 12/2016
14	Glycoproteins (Glycoprotein)IBA 01/2019 - 06/2002
13	Lipoprotein(a)IBA 05/2024 - 01/2020
12	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2024 - 01/2018
12	Proprotein Convertase 9IBA 01/2023 - 01/2018
12	Angiotensin Receptor AntagonistsIBA 01/2023 - 09/2011
12	salicylhydroxamic acid (SHAM)IBA 10/2022 - 04/2014
12	Heparin (Liquaemin)FDA LinkGeneric 11/2020 - 01/2003
10	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 04/2024 - 01/2021

Therapy/Procedure

384	Therapeutics 05/2024 - 06/2002
200	Percutaneous Coronary Intervention 02/2024 - 01/2002
137	Stents 03/2024 - 01/2002
55	Secondary Prevention 11/2023 - 05/2003
38	Drug-Eluting Stents 08/2023 - 06/2006
34	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2024 - 04/2006
28	Length of Stay 12/2023 - 11/2009
21	Transcatheter Aortic Valve Replacement 11/2023 - 06/2012
19	Denervation 01/2023 - 09/2012
19	Catheters 01/2023 - 09/2004
17	Surgical Amputation (Amputations) 04/2024 - 07/2009
17	Bariatric Surgery 11/2020 - 05/2010
13	Thrombolytic Therapy 01/2023 - 08/2014
13	Patient Readmission 01/2021 - 02/2004
12	Thrombectomy 01/2023 - 12/2008
11	Blood Transfusion (Blood Transfusions) 02/2022 - 01/2003
11	Glycemic Control 01/2021 - 08/2004